Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations.
Arnon J, Tabi M, Rottenberg Y, Zick A, Blumenfeld P, Hamburger T, Pikarsky E, Avraham E, Levine L, Popovtzer A, Yablonski-Peretz T, Kadouri L, Nechushtan H. Arnon J, et al. Among authors: popovtzer a. Cancers (Basel). 2023 Sep 26;15(19):4733. doi: 10.3390/cancers15194733. Cancers (Basel). 2023. PMID: 37835426 Free PMC article.
Outcomes of extracranial stereotactic body radiation therapy for induced oligometastatic non-small cell lung cancer on novel systemic therapy.
Tsur E, Blumenfeld P, Rottenberg Y, Nechushtan H, Arnon J, Wald O, Izhar U, Pfeffer R, Krakow A, Wygoda M, Popovtzer A, Michaeli TF. Tsur E, et al. Among authors: popovtzer a. Transl Lung Cancer Res. 2024 Mar 29;13(3):465-474. doi: 10.21037/tlcr-23-802. Epub 2024 Mar 22. Transl Lung Cancer Res. 2024. PMID: 38601442 Free PMC article.
Correction: Real world clinical experience using daily intelligence-assisted online adaptive radiotherapy for head and neck cancer.
Blumenfeld P, Arbit E, Den R, Salhab A, Michaeli TF, Wygoda M, Hillman Y, Pfeffer RM, Fang M, Misrati Y, Weizman N, Feldman J, Popovtzer A. Blumenfeld P, et al. Among authors: popovtzer a. Radiat Oncol. 2024 May 15;19(1):57. doi: 10.1186/s13014-024-02441-6. Radiat Oncol. 2024. PMID: 38750501 Free PMC article. No abstract available.
Extended Follow-Up Outcomes from Pooled Prospective Studies Evaluating Efficacy of Interstitial Alpha Radionuclide Treatment for Skin and Head and Neck Cancers.
Popovtzer A, Mizrachi A, D'Andrea MA, VanderWalde NA, Kurman N, Rosenfeld E, Ben-Hur R, Bellia SR, Feliciani G, Silvern D, Sarnelli A, Ballo MT, Patra P, Cohen GN, Damato AL, Shkedy Y, Den RB, Barker CA, Charas T, Hirshoren N. Popovtzer A, et al. Cancers (Basel). 2024 Jun 24;16(13):2312. doi: 10.3390/cancers16132312. Cancers (Basel). 2024. PMID: 39001374 Free PMC article.
An urgent call for the immediate release of Israeli hostages.
Paluch-Shimon S, Popovtzer A, Leibowitz R. Paluch-Shimon S, et al. Among authors: popovtzer a. Lancet. 2023 Oct 28;402(10412):1521. doi: 10.1016/S0140-6736(23)02288-2. Epub 2023 Oct 13. Lancet. 2023. PMID: 37844591 No abstract available.
Improving the response to lenvatinib in partial responders using a Constrained-Disorder-Principle-based second-generation artificial intelligence-therapeutic regimen: a proof-of-concept open-labeled clinical trial.
Sigawi T, Gelman R, Maimon O, Yossef A, Hemed N, Agus S, Berg M, Ilan Y, Popovtzer A. Sigawi T, et al. Among authors: popovtzer a. Front Oncol. 2024 Jul 30;14:1426426. doi: 10.3389/fonc.2024.1426426. eCollection 2024. Front Oncol. 2024. PMID: 39139285 Free PMC article.
126 results